We are live on ! Find out more
DB

Dmitry Balyasny Balyasny Asset Management

AUM $80.2B
1-Year Est. Return 51.53%
 

Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.

This Fund
S&P 500
This Quarter Est. Return
+8.03%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.37%
10 Year Est. Return
+1,172.21%
AUM
$29.2B
AUM Growth
+$5.23B
Cap. Flow
+$2.95B
Cap. Flow %
10.09%
Top 10 Hldgs %
12.75%
Holding
2,811
New
929
Increased
443
Reduced
394
Closed
643

Top Buys

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$230M
2
AMZN icon
Amazon
AMZN
+$158M
3
WFC icon
Wells Fargo
WFC
+$135M
4
SWK icon
Stanley Black & Decker
SWK
+$133M
5
HON icon
Honeywell
HON
+$128M

Sector Composition

Rank Sector Weight
1 Technology 13.11%
2 Industrials 11.28%
3 Financials 10.43%
4 Consumer Discretionary 9.72%
5 Healthcare 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPLI
2376
People Inc
PPLI
$2.86B
-272,815
Closed -$29.2M
IBB icon
2377
iShares Biotechnology ETF
IBB
$10.7B
-128,340
Closed -$20.8M
ICLN icon
2378
PUT
iShares Global Clean Energy ETF
ICLN
$2.09B
-100,000
Closed -$2.17M
ICLR icon
2379
Icon
ICLR
$13.3B
-37,785
Closed -$9.9M
ICUI icon
2380
ICU Medical
ICUI
$4.57B
-88,476
Closed -$20.6M
IFF icon
2381
International Flavors & Fragrances
IFF
$21.5B
-115,668
Closed -$15.5M
BRSL
2382
PUT
Brightstar Lottery PLC
BRSL
$2.21B
-510,000
Closed -$13.4M
NBP
2383
NovaBridge Biosciences American Depositary Shares
NBP
$231M
-3,000
Closed -$217K
IMAX icon
2384
IMAX
IMAX
$2.89B
-484,869
Closed -$9.2M
INCY icon
2385
CALL
Incyte
INCY
$25.9B
-451,000
Closed -$31M
INDI icon
2386
indie Semiconductor
INDI
$877M
-379,913
Closed -$4.68M
INSP icon
2387
Inspire Medical Systems
INSP
$1.8B
-27,250
Closed -$6.35M
INTC icon
2388
CALL
Intel
INTC
$476B
-20,000
Closed -$1.07M
INTA icon
2389
Intapp
INTA
$3.16B
-18,540
Closed -$478K
INTU icon
2390
CALL
Intuit
INTU
$100B
-40,000
Closed -$21.6M
IONS icon
2391
CALL
Ionis Pharmaceuticals
IONS
$9.93B
-130,000
Closed -$4.36M
IPHA
2392
Innate Pharma
IPHA
$252M
-187,484
Closed -$1.16M
IT icon
2393
Gartner
IT
$12.4B
-91,670
Closed -$27.9M
IVZ icon
2394
CALL
Invesco
IVZ
$14.1B
-310,000
Closed -$7.47M
IVZ icon
2395
Invesco
IVZ
$14.1B
-644,607
Closed -$15.5M
JBHT icon
2396
JB Hunt Transport Services
JBHT
$25.9B
-42,916
Closed -$7.18M
JBL icon
2397
Jabil
JBL
$32.8B
-165,871
Closed -$9.68M
JCI icon
2398
Johnson Controls International
JCI
$86.7B
-634,885
Closed -$43.2M
JEF icon
2399
Jefferies Financial Group
JEF
$12.1B
-28,699
Closed -$1.02M
JNJ icon
2400
Johnson & Johnson
JNJ
$651B
-586,748
Closed -$94.8M

Similar funds

Dmitry Balyasny's Q4 2021 Portfolio in Review

As of Q4 2021, Dmitry Balyasny held 2,811 positions worth $29.2B, up 22% from $24B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Dmitry Balyasny deployed $2.95B of net new capital in Q4 2021, opening 929 new positions and adding to 443 existing holdings. Its largest new stake was L3Harris: 1,037,704 shares worth $221M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 17% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $266M trimmed.

  • Dmitry Balyasny's largest Q4 2021 buy was L3Harris: 1,037,704 shares worth $221M.
  • Dmitry Balyasny added most to Honeywell in Q4 2021, an estimated $128M increase.
  • Dmitry Balyasny's biggest Q4 2021 reduction was Goldman Sachs, cutting an estimated $266M.
  • Dmitry Balyasny fully exited Kansas City Southern in Q4 2021, selling an estimated $209M.
  • Dmitry Balyasny's ten largest holdings make up 13% of its $29.2B portfolio in Q4 2021.
  • Dmitry Balyasny opened 929 new positions and closed 643 in Q4 2021.
  • Dmitry Balyasny's portfolio value rose 22% quarter-over-quarter to $29.2B.

Based on Balyasny Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.